c-LEcta: OFB starts construction work for the technology campus “BioSquare Leipzig”

FRANKFURT, Germany–(BUSINESS WIRE)–OFB Projektentwicklung started the first construction phase of the “BioSquare Leipzig” on a partial area of ​​about 11,600 m² on construction site 6a at the “Alte Messe”. The symbolic groundbreaking on 22 September 2022 took place in the presence of Thomas Dienberg (Mayor for Urban Development and Construction of the City of Leipzig), Dr. Mark Struhalla (CEO of c-LEcta GmbH) and Dr. Christoph Wichmann ( Office manager for Leipzig at OFB Projektentwicklung). The ceremony marks the beginning of a state-of-the-art biotech and life sciences campus that consists of several buildings. Excavation of about 35,000 m³ of soil is expected to be completed by mid-November this year.

Back in February 2022, a facade competition was held for the project with five architectural bureaus and a jury consisting of politicians, architects, scientists, the tenant c-LEcta and the OFB. Leipzig-based firm KLM Architekten und Ingenieure GmbH has already been commissioned as the construction designer for the first construction phase with the facade design.

Above ground, the first construction phase consists of two independent buildings with a total of approximately 18,500 m² of leasable area. Five floors are planned for building A, which will be used in the future by the biotech company c-LEcta GmbH and will have around 10,500 m² of above-ground leasable space.

c-LEcta has been located at the “Alte Messe” site since the company was founded in 2004 and moved to its headquarters in the BioCube in 2012. The company has changed significantly since then: What started as a spin-off of a university with five employees has now evolved into a leading global player in industrial biotechnology. In 2021, c-LEcta works with more than 400 customers from more than 40 countries in the food and pharmaceutical industry and again significantly increased its sales compared to the previous year. Along with this, the number of employees has also developed rapidly over the years. Since 2018 alone, their number has doubled to 120 employees. Further growth of the workforce is also planned in the coming years, so there will not be enough space for office and laboratory space in the current building.

The neighboring building B in the direction of Prager Strasse consists of seven floors and thus offers a view of the old trade fairs after their completion. The slight displacement of the second building will create a forecourt that provides attractive access to building B with a good quality of stay. In addition, a common underground parking garage with about 110 parking spaces is being built.

Construction work on c-Lecta’s new corporate headquarters is scheduled to be completed in the first half of 2025. An additional 8,000 m² of leasable space is being created in the second building of the first construction phase. With floor heights of four meters and modern construction grids, the two buildings offer maximum flexibility in terms of use, so that both office space and laboratory space can be realized.

“The development of the BioSquare project underlines the importance of Leipzig as an innovative center for biotechnology and life sciences. We want to keep innovative companies in these future industries in place and attract new ones. Of course, we are particularly pleased that c-LEcta, a Leipzig success story, is moving into the first construction phase,” said mayor and advisor for urban development and construction of the city of Leipzig, Thomas Dienberg.

“The groundbreaking ceremony for our new headquarters in Leipzig is obviously a very special moment. In 2025, we will move here to a high-tech building with state-of-the-art workplaces and laboratories. This will not only provide enough space for further development in the long term, but at the same time provide a state-of-the-art design concept for our employees. Cooperation, concentrated work and regeneration go hand in hand. We are happy that we can continue our history in our birthplace,” they emphasized Dr. A.S. Mark Struhala, CEO of tenant c-LEcta.

Dr. Christoph Wichmann, head of the OFB office in Leipzig, is also quite pleased: “It’s great to see that the excavators are already rolling and the implementation phase of BioSquare has begun. The “Alte Messe” has made a name for itself as a place for innovative companies. On our campus, we offer research institutions and technology companies completely new development opportunities and perfect framework conditions.”

The project site is within sight of the well-known double M of the Leipzig Mustermesse. The nearby S-Bahn station “Völkerschlachtdenkmal” as well as several tram and bus lines offer very good public transport connections. The motorway ring road can also be reached in less than five minutes. Several innovative research institutions and companies such as Fraunhofer IZI, the Max Planck Institute, Bio-City or the German Center for Integrative Biodiversity Research (iDiv) have established themselves at the “Alte Messe” location in recent years.


OFB Projektentwicklung GmbH has been in the real estate business for over 60 years. And he’s still as dedicated as he was on day one. As a subsidiary of Landesbank Hessen-Thüringen and part of the Helaba Immobiliengruppe, high-quality and sustainable large-scale real estate is our focus. Project development, project management and real estate management are our passion.

At our head office in Frankfurt am Main and at our branches in Berlin, Erfurt, Munich, Düsseldorf and Leipzig, around 140 employees implement successful real estate projects throughout Germany. In doing so, we want to work harder than others – and therefore take into account the interplay of economic, environmental and social components already at the planning stage of our projects. The goal: to further develop our projects as well as ourselves.


About c-LEcta

c-LEcta is a global biotechnology company specializing in the development, manufacture and distribution of enzyme products. The company uses world-class enzyme engineering and manufacturing technologies to provide its partners in the food and pharmaceutical industries with superior biotechnology solutions for innovative industrial applications. Product development is based on the proprietary ENESYZ® enzyme technology platform and is carried out both in-house and in close collaboration with industrial partners worldwide. c-LEcta supplies its products to more than 400 customers in over 40 countries. c-LEcta currently has more than 120 employees at its headquarters in Leipzig.

c-LEcta is part of the Kerry Group. Kerry is a leading global flavor and nutrition partner for the food, beverage and pharmaceutical markets. The company employs 22,000 people in over 150 locations and uses its broad range of ingredient solutions to innovate with its customers and create great-tasting products with improved nutrition and functionality, while providing a better impact on the planet.

Leave a Comment

Your email address will not be published.